InsidersTradesSigma
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Browse the full record of transactions filed by Panacea Innovation Ltd. Director active across 2 companies, notably Atara Biotherapeutics, Inc.. Cumulatively, 5 filings have been published. Breakdown: 2 buys · 1 sell. Total volume traded: €1.2m. History available since 17 July 2025. The latest transaction was filed on 17 March 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations
Panacea Innovation Ltd has filed 5 disclosures in total. In the 5 most recent filings sampled, they concern Atara Biotherapeutics, Inc. and cover the period from 2025-07-21 to 2026-03-19, with EUR 735855 of buys and EUR 420708 of sells. The most common transaction nature is Levée d'options.